RxDoctor Payments Data

Audra Fegley

Psychiatric/Mental Health · Knoxville, TNNPI 1932340361

Payments from drug & device makers

$5,680in general payments, 2019–2025

Across 309 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$848
  • AbbVie$795
  • Teva Pharmaceuticals USA, Inc.$551
  • Otsuka America Pharmaceutical, Inc.$521
  • Supernus Pharmaceuticals, Inc.$514
  • Neurocrine Biosciences, Inc.$448
  • plus $2K from 14 others

What the payments were for

  • Food & beverage$5,680100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,680 in reported general payments places this provider in the 90th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee

Medicare billing

Part B allowed, 2024
$11,767
Medicare patients
20
Services billed
155

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine12$156,244
MydayisDextroamphetamine/Amphetamine12$3,872
Desvenlafaxine Succinate ErDesvenlafaxine Succinate20$1,309
Bupropion XlBupropion Hcl18$902
Quetiapine Fumarate37$762
Lamotrigine42$696
Trazodone Hcl29$615
Duloxetine Hcl22$480
Modafinil12$415
Gabapentin41$397
Buspirone Hcl21$354
Venlafaxine Hcl ErVenlafaxine Hcl18$329
Fluoxetine Hcl21$226
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine12$199
Topiramate19$165

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$551$156,24412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,167 psychiatric/mental health providers in Tennessee.

Other psychiatric/mental health in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →